ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,247
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study
Author(s):
U Pelzer
,
K Kubica
,
J. Stieler
Publication date:
2008
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Gastroenterology
Data availability:
ScienceOpen disciplines:
Medicine
,
Gastroenterology & Hepatology
Comments
Comment on this article
Sign in to comment
Similar content
3,247
A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study
Authors:
KKU Pelzer
,
J. Stieler
,
I Schwaner
…
Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer (CONKO 003)
Authors:
H Oettle
,
U Pelzer
,
J. Stieler
Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive careversus best supportive care alone (BSC) in second-line therapy ofgemcitabine-refractory advanced pancreatic cancer (CONKO 003)
Authors:
H Oettle
,
U Pelzer
,
J. Stieler
See all similar
Cited by
1
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
Authors:
Laetitia Dahan
,
Frank Bonnetain
,
Marc Ychou
…
See all cited by